BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29975580)

  • 1. DIFFERENTIAL REGULATION OF 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ACTIVITY IN PATIENTS WITH DIFFERING ETIOLOGIES OF HYPOPITUITARISM.
    Agha A; Behan LA; Forde H; Taylor NF; Smith D; Thompson CJ; Drake WM; Monson JP
    Endocr Pract; 2018 Oct; 24(10):875-881. PubMed ID: 29975580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone, insulin-like growth factor-I and the cortisol-cortisone shuttle.
    Stewart PM; Toogood AA; Tomlinson JW
    Horm Res; 2001; 56 Suppl 1():1-6. PubMed ID: 11786677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of regulation of 11beta-hydroxysteroid dehydrogenase type 1 during short-term manipulation of GH in patients with hypopituitarism.
    Sigurjonsdottir HA; Andrew R; Stimson RH; Johannsson G; Walker BR
    Eur J Endocrinol; 2009 Sep; 161(3):375-80. PubMed ID: 19549748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11 beta-hydroxysteroid dehydrogenase activity.
    Gelding SV; Taylor NF; Wood PJ; Noonan K; Weaver JU; Wood DF; Monson JP
    Clin Endocrinol (Oxf); 1998 Feb; 48(2):153-62. PubMed ID: 9579226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of growth hormone deficiency and replacement on glucocorticoid exposure in hypopituitary patients on cortisone acetate and hydrocortisone replacement.
    Swords FM; Carroll PV; Kisalu J; Wood PJ; Taylor NF; Monson JP
    Clin Endocrinol (Oxf); 2003 Nov; 59(5):613-20. PubMed ID: 14616886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of cortisol metabolism by low-dose growth hormone replacement in elderly hypopituitary patients.
    Toogood AA; Taylor NF; Shalet SM; Monson JP
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1727-30. PubMed ID: 10770221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of glucocorticoid metabolism by the growth hormone - IGF-1 axis.
    Agha A; Monson JP
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):459-65. PubMed ID: 17371460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simple LC-MS/MS method for the determination of cortisol, cortisone and tetrahydro-metabolites in human urine: assay development, validation and application in depression patients.
    Zhai X; Chen F; Zhu C; Lu Y
    J Pharm Biomed Anal; 2015 Mar; 107():450-5. PubMed ID: 25668797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone (GH) substitution in GH-deficient patients inhibits 11beta-hydroxysteroid dehydrogenase type 1 messenger ribonucleic acid expression in adipose tissue.
    Paulsen SK; Pedersen SB; Jørgensen JO; Fisker S; Christiansen JS; Flyvbjerg A; Richelsen B
    J Clin Endocrinol Metab; 2006 Mar; 91(3):1093-8. PubMed ID: 16368752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of growth hormone replacement on cortisol metabolism in hypopituitary patients treated with cortisone acetate.
    Beentjes JA; Kerstens MN; Dullaart RP
    Scand J Clin Lab Invest; 2001 Jul; 61(4):277-86. PubMed ID: 11465341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone replacement inhibits renal and hepatic 11 beta-hydroxysteroid dehydrogenases in ACTH-deficient patients.
    Walker BR; Andrew R; MacLeod KM; Padfield PL
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):257-63. PubMed ID: 9828916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline characteristics and response to 2 years of growth hormone (GH) replacement of hypopituitary patients with GH deficiency due to adult-onset craniopharyngioma in comparison with patients with nonfunctioning pituitary adenoma: data from KIMS (Pfizer International Metabolic Database).
    Verhelst J; Kendall-Taylor P; Erfurth EM; Price DA; Geffner M; Koltowska-Häggström M; Jönsson PJ; Wilton P; Abs R
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4636-43. PubMed ID: 15928246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo activity of 11beta-hydroxysteroid dehydrogenase type 1 and free fatty acid-induced insulin resistance.
    Mai K; Kullmann V; Bobbert T; Maser-Gluth C; Möhlig M; Bähr V; Pfeiffer AF; Spranger J; Diederich S
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):442-9. PubMed ID: 16181237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates.
    Tsilchorozidou T; Honour JW; Conway GS
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5907-13. PubMed ID: 14671189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of 11β-HSD1 by GH/IGF-1 in key metabolic tissues may contribute to metabolic disease in GH deficient patients.
    Morgan SA; Berryman DE; List EO; Lavery GG; Stewart PM; Kopchick JJ
    Growth Horm IGF Res; 2022 Feb; 62():101440. PubMed ID: 34814007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced 11beta-hydroxysteroid dehydrogenase type 1 activity in obese boys.
    Wiegand S; Richardt A; Remer T; Wudy SA; Tomlinson JW; Hughes B; Grüters A; Stewart PM; Strasburger CJ; Quinkler M
    Eur J Endocrinol; 2007 Sep; 157(3):319-24. PubMed ID: 17766714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of cortisol metabolism during treatment of acromegaly is independent of body composition and insulin sensitivity.
    Frajese GV; Taylor NF; Jenkins PJ; Besser GM; Monson JP
    Horm Res; 2004; 61(5):246-51. PubMed ID: 15004437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity.
    Rask E; Walker BR; Söderberg S; Livingstone DE; Eliasson M; Johnson O; Andrew R; Olsson T
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3330-6. PubMed ID: 12107245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sexual dimorphism of cortisol metabolism is maintained in elderly subjects and is not oestrogen dependent.
    Toogood AA; Taylor NF; Shalet SM; Monson JP
    Clin Endocrinol (Oxf); 2000 Jan; 52(1):61-6. PubMed ID: 10651754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of growth hormone replacement therapy on adrenal androgen secretion in adult onset hypopituitarism.
    Isidori AM; Kaltsas GA; Perry L; Burrin JM; Besser GM; Monson JP
    Clin Endocrinol (Oxf); 2003 May; 58(5):601-11. PubMed ID: 12699442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.